Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial

Main Category: Diabetes
Also Included In: Clinical Trials / Drug Trials
Article Date: 26 Feb 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Associated Foot & Ankle Specialists announced it is recruiting patients with foot ulcers due to diabetes to participate in the MATRIX clinical trial. The trial will study the effects of a new product, Excellarate, for the potential treatment of patients with non-healing diabetic foot ulcers. Excellarate is an investigational product designed to stimulate the process of wound healing.

The MATRIX trial is a randomized, double-blind safety and efficacy research study in which Excellarate is topically administered once or twice over the course of the study, with a goal of complete ulcer closure at 12 weeks or earlier.

"The Excellarate topical gel, using Gene Activated Matrix (GAM) technology is designed to provide release of the platelet-derived growth factor BB protein, which stimulates angiogenesis (the growth of new blood vessels) and granulation tissue formation, the building blocks for a variety of wound healing processes," stated Arthur J. Tallis, D.P.M., Podiatric Physician & Surgeon at Associated Foot & Ankle Specialists and a trial investigator.

There are currently more than 20 million Americans who have diabetes and this number is expected to double by the year 2030. Many diabetic patients suffer from peripheral neuropathy, or a loss of feeling in their feet, that puts them at increased risk of foot ulceration. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Patients with non-healing ulcers are more susceptible to infections that may lead to amputation of the affected foot or leg.

Associated Foot & Ankle Specialists is among only 25 sites participating in the MATRIX trial. The trial is expected to enroll 210 patients nationwide.

Associated Foot & Ankle Specialists
http://www.footanklespecialists.com

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Associated Foot & Ankle Specialists. "Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial." Medical News Today. MediLexicon, Intl., 26 Feb. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/98486.php>

APA
Associated Foot & Ankle Specialists. (2008, February 26). "Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/98486.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »